Larite Industries Ltd.
| BSE: 512325 | Sector: Health care |
| NSE: N.A. | ISIN Code: N.A. |
| BSE 05:30 | 01 Jan | Larite Industries Ltd |
| NSE 05:30 | 01 Jan | Larite Industries Ltd |
Larite Industries Ltd. (LARITEINDS) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 913.40 | -0.72 | 966.90 | 733.95 | 219152.06 |
| Divi's Lab. | 3728.20 | -5.56 | 5425.00 | 3365.10 | 98965.07 |
| Cipla | 1027.35 | -1.06 | 1083.15 | 850.00 | 82907.14 |
| Dr Reddy's Labs | 4262.25 | 0.12 | 5078.80 | 3655.00 | 70940.89 |
| Apollo Hospitals | 4309.85 | -2.81 | 5930.70 | 3365.90 | 61967.02 |
| Torrent Pharma. | 1539.20 | 0.26 | 1652.23 | 1242.50 | 52092.69 |
| Piramal Enterp. | 1919.95 | 0.72 | 3013.00 | 1561.00 | 45819.61 |
| Abbott India | 18761.95 | -0.95 | 23902.30 | 15525.00 | 39869.14 |
| Zydus Lifesci. | 386.90 | 1.35 | 576.25 | 319.40 | 39606.95 |
| Gland Pharma | 2363.30 | 0.67 | 4350.00 | 2180.10 | 38923.55 |
| Biocon | 311.30 | -1.41 | 410.50 | 305.00 | 37374.68 |
| Alkem Lab | 2959.90 | -0.49 | 4067.70 | 2835.00 | 35385.60 |
| Max Healthcare | 361.55 | -2.74 | 472.60 | 301.70 | 35056.97 |
| Aurobindo Pharma | 593.30 | 3.10 | 864.30 | 503.40 | 34761.45 |
| Lupin | 682.60 | -1.06 | 1037.00 | 583.05 | 31034.41 |
| Laurus Labs | 565.75 | 0.12 | 723.55 | 433.20 | 30400.58 |
| Glaxosmi. Pharma | 1441.95 | -0.02 | 1917.00 | 1372.80 | 24428.08 |
| Syngene Intl. | 591.40 | 1.64 | 686.00 | 508.10 | 23740.57 |
| Ipca Labs. | 928.00 | -8.62 | 1383.55 | 831.40 | 23543.36 |
| Fortis Health. | 281.85 | 4.14 | 313.80 | 219.80 | 21278.55 |
Quick Links for Larite Industries:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
